Quality & Compliance For Continuous Improvement

Essential Learning Resources from NSF International, Pharma Biotech

Have A Question? Get In Touch

Check out some of our latest learning resources and get your company into the quality mindset with our short video.

Being in compliance doesn't equal good quality. In this NSF video, expert Maxine Fritz, Executive Vice President, Pharma Biotech, provides an overview of our team and capabilities, including how we follow a holistic quality approach to help you build the right quality mindset, anywhere across the globe. Watch the video >>

For more information on our services including auditing, consultancy, quality systems, regulatory guidance and training, contact pharmamail@nsf.org or visit www.nsfpharmabiotech.org

Webinar: Using Behavioral GMP to Create Perpetual GMP Inspection Readiness

White Paper: How to Write to Regulatory Agencies When Things Go Wrong

White Paper: The Future of the Pharmaceutical Industry

Video: Is Your Pharmaceutical Facility Aging?

Using Behavioral GMP to Create Perpetual GMP Inspection Readiness

How do the best companies remain inspection ready by design rather than good fortune? In this webinar, John Johnson covers what perpetual GMP compliance means and details how you and your organization can achieve it. He also introduces the basic toolkit used for inspection preparation.

How to Write to Regulatory Agencies When Things Go Wrong

Responding to severe regulatory criticism? Need some essential guidance? This white paper includes step-by-step guidance on how to write to regulatory agencies when things go wrong.

The Future of the Pharmaceutical Industry

In this white paper, Martin Lush explains his view of the future of the pharmaceutical industry, and provides some key facts and essential back-to-basics advice on how you can prosper in an uncertain, ever-changing world.

Aging Facilities

Aging facilities is a relatively new issue impacting the pharma biotech industry. Just because your facility is chronologically older, doesn’t necessarily mean it is aging! In this short video, expert Nicholas Markel explains the issue, how to find out if you have an aging facility (by addressing five key questions) and how to prevent aging facilities.

A Beginner’s Guide To Quality Risk Management (QRM)  

The pharmaceutical industry approach to assessing and controlling quality risks has largely been empirical. This is often fine but in more complex or hazardous situations, the pharmaceutical industry could benefit from a number of very helpful tools and techniques. 

> > Discover more

SIGN UP FOR YOUR COMPLIMENTARY PHARMA JOURNAL AND MONTHLY E-JOURNAL – VISIT OUR WEBSITE 

Stay in touch - follow us on 

Go to article: Home | Trust In Big PharmaGo to article: EditorialGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: FreudenbergGo to article: The Pharma Industry BriefingGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: Humira: the highs and lows of the world’s most successful drug Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Gene therapy: talking smart solutions with Bluebird BioGo to article: Moehs Iberica Company InsightGo to article: Moehs Iberica SLGo to article: A research headache: improving the understanding of chronic migraine Go to article: SensitechGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Philanthropy in pharma: a look inside the ISPE FoundationGo to article: DelSiTechGo to article: Novel Oral Therapies Are An Unmet Need For Ulcerative ColitisGo to article: PhoenixGo to article: FDA removes key barrier to US biosimilar developmentGo to article: Nipro PharmaPackagingGo to article: Pfizer price hikes: do rare cancer drugs warrant higher prices?Go to article: AlpexGo to article: Head-to-head: competing for the most effective psoriasis drugGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Takeda to seek label expansion for Ninlaro in multiple myelomaGo to article: Capsugel Company InsightGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s EpidiolexGo to article: EcocoolGo to article: Abiogen PharmaGo to article: Illegal online pharmacies: how endemic are they?Go to article: Global Freight Solutions LtdGo to article: The boom in medical cannabis research is set to continueGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Population boom will boost acute stroke market, particularly in ChinaGo to article: Pall BiotechGo to article: Cryo StoreGo to article: Watch Alibaba instead of Amazon in healthcareGo to article: WIKA - Disaster preventionGo to article: AstraZeneca’s Lynparza maintains lead in PARP inhibitor raceGo to article: G.F.Go to article: Erdmann Design SwitzerlandGo to article: CMV presents a serious concern in HIV+ personsGo to article: BEA TechnologiesGo to article: BaxterGo to article: bDMARD therapy: adherence in the first year is key to successGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: End the struggle: pathways to HEAL the opioid crisisGo to article: LaudaGo to article: AbbVie poised to overtake Gilead as hepatitis C leaderGo to article: ILC Dover IncGo to article: ViiV results show the importance of INIs to future HIV treatmentGo to article: PfanstiehlGo to article: Novartis acquires rights to atopic dermatitis candidate MOR106Go to article: Niconex Medical LtdGo to article: EventsGo to article: Next issue